CLL Therapy Approaches in Russia

Trial Identifier: D8220R00038
Sponsor: AstraZeneca
Start Date: October 2021
Primary Completion Date: December 2027
Study Completion Date: December 2027
Condition: CLL (Chronic Lymphocytic Leukemia)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Russia Belgorod, Russia
Russia Bryansk, Russia
Russia Chelyabinsk, Russia
Russia Chita, Russia
Russia Ekaterinburg, Russia
Russia Irkutsk, Russia
Russia Kaliningrad, Russia
Russia Kaluga, Russia
Russia Kazan, Russia
Russia Kirov, Russia
Russia Krasnoyarsk, Russia
Russia Kurgan, Russia
Russia Mahachkala, Russia
Russia Moscow, Russia
Russia Nizhny Novgorod, Russia
Russia Novosibirsk, Russia
Russia Omsk, Russia
Russia Orenburg, Russia
Russia Perm, Russia
Russia Petropavlovsk-Kamchatskii, Russia
Russia Petrozavodsk, Russia
Russia Rostov na Donu, Russia
Russia Saint-Petesburg, Russia
Russia Samara, Russia
Russia Saratov, Russia
Russia Syktyvkar, Russia
Russia Tver, Russia
Russia Ufa, Russia
Russia Ulan-Ude, Russia
Russia Vladimir, Russia
Russia Vladivostok, Russia
Russia Volgograd, Russia
Russia Vologda, Russia
Russia Yaroslavl, Russia